Lung cancer has long stood as the most formidable cancer killer, burdened not only by late-stage diagnoses but also by decades of stigma and fatalism. Today, however, the landscape is shifting. Advances in screening, therapeutics, and survivorship have created a new reality; lung cancer is treatable, survivable, and increasingly understood as a chronic disease for many. The accompanying editorial from the American Cancer Society National Lung Cancer Roundtable [1] chronicles this progress and th…